MALACRIDA, ALESSIO
 Distribuzione geografica
Continente #
AS - Asia 7.395
NA - Nord America 6.354
EU - Europa 3.022
SA - Sud America 622
AF - Africa 114
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.522
Nazione #
US - Stati Uniti d'America 6.059
VN - Vietnam 3.743
SG - Singapore 1.418
IT - Italia 878
CN - Cina 871
HK - Hong Kong 512
DE - Germania 503
BR - Brasile 491
RU - Federazione Russa 414
CA - Canada 231
SE - Svezia 220
GB - Regno Unito 194
IN - India 163
KR - Corea 140
IE - Irlanda 132
FR - Francia 128
ID - Indonesia 107
AT - Austria 100
BD - Bangladesh 88
FI - Finlandia 70
UA - Ucraina 64
LT - Lituania 53
JP - Giappone 51
DK - Danimarca 45
ES - Italia 44
MX - Messico 44
AR - Argentina 43
IQ - Iraq 41
TR - Turchia 39
NL - Olanda 38
SA - Arabia Saudita 37
PL - Polonia 36
ZA - Sudafrica 36
TW - Taiwan 35
BE - Belgio 29
PK - Pakistan 26
EC - Ecuador 22
CH - Svizzera 21
PH - Filippine 18
VE - Venezuela 17
CO - Colombia 16
MY - Malesia 16
MA - Marocco 15
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
KE - Kenya 13
UZ - Uzbekistan 12
RO - Romania 11
AU - Australia 10
PY - Paraguay 10
TN - Tunisia 10
CL - Cile 9
KZ - Kazakistan 8
AZ - Azerbaigian 7
GR - Grecia 7
CR - Costa Rica 6
NP - Nepal 6
JM - Giamaica 5
OM - Oman 5
PE - Perù 5
AM - Armenia 4
AO - Angola 4
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
EU - Europa 4
TH - Thailandia 4
UG - Uganda 4
UY - Uruguay 4
CY - Cipro 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
LY - Libia 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
KW - Kuwait 1
Totale 17.509
Città #
Ann Arbor 1.168
Ho Chi Minh City 1.166
Hanoi 952
Singapore 841
Dallas 829
Ashburn 543
San Jose 503
Hong Kong 499
Frankfurt am Main 362
Milan 289
Wilmington 197
Los Angeles 169
Chandler 154
Beijing 151
New York 141
Toronto 139
Dublin 131
Hefei 131
Fairfield 128
Santa Clara 122
Haiphong 116
Council Bluffs 110
Boardman 108
Chicago 98
Seoul 98
Biên Hòa 92
Da Nang 90
Ha Long 90
Vienna 83
Woodbridge 78
Hải Dương 75
Quận Bình Thạnh 75
Jakarta 71
Dearborn 67
Houston 65
Buffalo 59
Ninh Bình 56
Princeton 54
The Dalles 54
Thái Nguyên 53
Columbus 51
São Paulo 51
Lauterbourg 49
Can Tho 48
Vũng Tàu 47
Shanghai 44
Quận Một 43
Bắc Giang 42
Bắc Ninh 41
Cambridge 40
Jacksonville 39
Munich 39
Seattle 39
London 37
Quận Phú Nhuận 37
Vilnius 36
Helsinki 35
Moscow 35
Orem 35
Chennai 33
Phủ Lý 32
Warsaw 32
Tokyo 30
Quận Sáu 29
Rome 28
Pune 27
Montreal 25
Nanjing 25
Điện Bàn 25
Nuremberg 22
Quảng Ninh 22
Brooklyn 21
Kaohsiung 21
Kent 21
Vinh 21
Quận Bảy 20
Appiano Gentile 19
Lang Son 19
Phoenix 19
Poplar 19
Rio de Janeiro 19
Stockholm 19
Turin 19
Boston 18
Brussels 17
Denver 17
Johannesburg 17
Manchester 17
San Diego 17
Thu Dau Mot 17
Zurich 17
Brasília 16
Lappeenranta 16
Lawrence 16
Thái Bình 16
Mexico City 15
Pavia 15
Quận Mười 15
Baghdad 14
Desio 14
Totale 11.836
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.119
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 754
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 604
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 594
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 544
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 507
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 487
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 453
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 437
EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS 407
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 406
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 398
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 390
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 375
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 372
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 351
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 336
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 323
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 321
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 313
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 309
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 298
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 295
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 293
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 291
Are sigma receptor modulators a weapon against multiple sclerosis disease? 285
Neurodegeneration: can metabolites from Eremurus persicus help? 283
The Role of NMNAT2/SARM1 in Neuropathy Development 281
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 280
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 279
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 272
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 272
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 270
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 263
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 255
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 247
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 239
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 238
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 236
Rigosertib and cholangiocarcinoma: A cell cycle affair 236
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 231
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 229
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 225
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 216
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 212
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 209
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 194
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 157
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 154
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 135
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 87
Molecular Mechanisms of Proteasome Inhibitor-Induced Peripheral Neuropathy 65
Recent advances in the discovery of ALKBH 1–8 inhibitors 47
MECHANISTIC IMPLICATIONS OF TUBULIN POST- TRANSLATIONAL MODIFICATIONS IN A PRECLINICAL MODEL OF PROTEASOME INHIBITOR- INDUCED PERIPHERAL NEUROPATHY 41
Proteasome inhibitors-based chemotherapy-induced neurotoxicity: mitochondrial, calcium signalling and cytoskeleton alterations 40
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicity 28
From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation 14
Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib 13
Totale 18.089
Categoria #
all - tutte 47.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/2022643 63 92 77 53 42 56 30 30 20 25 50 105
2022/20231.012 94 221 158 88 80 121 31 63 55 21 52 28
2023/2024668 24 23 31 23 65 138 91 37 48 21 7 160
2024/20252.793 183 175 189 134 263 180 188 90 296 362 238 495
2025/202610.629 3.240 1.378 1.108 785 632 355 1.020 314 495 618 414 270
Totale 18.089